Most events included nausea, diarrhoea, and vomiting and were mild to moderate
This MDL consolidates federal lawsuits filed across the country that allege GLP-1 receptor agonist drugs commonly prescribed for type 2 diabetes and weight loss caused NAION, a condition that damages the optic nerve and can result in sudden, permanent vision loss
Initially developed as a treatment for diabetes, the drug acts to stimulate the secretion of insulin, as well as suppress appetite by delaying gastric emptying and promoting satiety
If Medicare, Medicaid, or commercial insurance plans are part of your coverage, Klinic reassures cost visibility by verifying your insurance before treatments commence
Los pacientes con retinopata diabtica deben ser referidos a oftalmologa antes o durante el tratamiento